192 related articles for article (PubMed ID: 36209236)
1. Urinary microbiota and prostatic diseases: the key for the lock? A systematic review.
Mjaess G; Karam A; Roumeguère T; Diamand R; Aoun F; McVary K; Moul JW; De Nunzio C; Albisinni S
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):451-460. PubMed ID: 36209236
[TBL] [Abstract][Full Text] [Related]
2. [The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia].
Zhiborev AB; Martov AG
Urologiia; 2018 Oct; (4):81-87. PubMed ID: 30761794
[TBL] [Abstract][Full Text] [Related]
3. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
4. Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature.
Karam A; Mjaess G; Albisinni S; El Daccache Y; Farah M; Daou S; Kazzi H; Hassoun R; Bou Kheir G; Aoun F; Roumeguère T
World J Urol; 2022 Apr; 40(4):951-964. PubMed ID: 34997296
[TBL] [Abstract][Full Text] [Related]
5. Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.
Freitas D; Andriole GL; Freedland SJ; Neto BS; Moreira DM
Urology; 2019 Jul; 129():160-164. PubMed ID: 30914334
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
7. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary approach to prostatitis.
Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
10. The impact of urine microbiota in patients with lower urinary tract symptoms.
Lee HY; Wang JW; Juan YS; Li CC; Liu CJ; Cho SY; Yeh HC; Chueh KS; Wu WJ; Wu DC
Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):23. PubMed ID: 33858430
[TBL] [Abstract][Full Text] [Related]
11. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
Chiang BJ; Kuo HC; Liao CH
Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistance.
Zhao S; Wang Y; Wu W; Yang S; Feng L; Tao F; Ge W; Shen M; Xu W
Andrologia; 2021 Jul; 53(6):e14060. PubMed ID: 33782980
[TBL] [Abstract][Full Text] [Related]
13. The role of prostatic inflammation in the development and progression of benign and malignant diseases.
Gandaglia G; Zaffuto E; Fossati N; Cucchiara V; Mirone V; Montorsi F; Briganti A
Curr Opin Urol; 2017 Mar; 27(2):99-106. PubMed ID: 27906778
[TBL] [Abstract][Full Text] [Related]
14. [Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer].
Zhang F; Si-Mu-Jiang-Abula A; Zhang LD
Zhonghua Nan Ke Xue; 2014 Apr; 20(4):354-8. PubMed ID: 24873164
[TBL] [Abstract][Full Text] [Related]
15. [The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis].
Kuzmenko AV; Vinnik YY; Kuzmenko VV; Gyaurgiev TA
Urologiia; 2021 Jun; (3):70-74. PubMed ID: 34251104
[TBL] [Abstract][Full Text] [Related]
16. Impacts of histological prostatitis on sexual function and lower urinary tract symptoms in patients with benign prostatic hyperplasia.
Wang GC; Zheng JH; Yang B; Che JP; Yan Y; Geng J; Liu M; Huang JH; Xia SQ; Peng B
Urology; 2013 Nov; 82(5):1094-7. PubMed ID: 23915513
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of long-term results of the use of entomological drug in the combination therapy of patients with benign prostatic hyperplasia and chronic prostatitis].
Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA; Kuzmenko GA
Urologiia; 2022 Dec; (6):30-35. PubMed ID: 36625610
[TBL] [Abstract][Full Text] [Related]
18. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.
De Nunzio C; Salonia A; Gacci M; Ficarra V
World J Urol; 2020 Nov; 38(11):2771-2779. PubMed ID: 32060633
[TBL] [Abstract][Full Text] [Related]
19. [Prostatic secretion microbiota: a comparative analysis of the hronical prostatitis II and IIIA category].
Kogan MI; Naboka YL; Ismailov RS
Urologiia; 2020 Apr; (2):16-22. PubMed ID: 32351058
[TBL] [Abstract][Full Text] [Related]
20. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
